GSA Technology Council

Germany’s Largest Clinical Provider Enhances Collexis Expert Profiling System

Collexis Holdings, Inc. announced today that the Asklepios Group, which operates hospitals and specialized rehabilitation clinics in Europe and the United States, has incorporated the voice and video communication functionalities of Microsoft Office Communications Server 2007, providing information about the availability of experts and direct voice and video communication possibilities.

“Utilizing SharePoint and new technologies from the unified communications stack, we’ve worked with Collexis to connect Asklepios caregivers to existing expertise and knowledge within their network — meaning that patients reap the benefits of faster access to the best of what the healthcare institutions have to offer,” said Tim Smokoff, General Manager, Worldwide Health, Microsoft. “Increased communication between physician and patient as well as between healthcare providers is an important factor in enhancing the satisfaction of patients and staff while still helping improve treatment quality at affordable prices.”

Collexis’ proprietary “Fingerprinting” technology analyzed scientific and medical texts to develop Expert Profiles of Asklepios’ physicians and researchers. The result is a detailed “Knowledge Map” of the Group’s shared expertise. Working with Microsoft Office SharePoint Server, Asklepios providers can instantly search a central knowledge and skills management system in order to better diagnose and treat patients. Within seconds, providers can then draw on the experience of a colleague in another Asklepios clinic for advice on a disease, diagnosis or therapy.

The Collexis expert profiling solution in combination with the unified communication functionalities from Microsoft redefine the concept of medical cooperation, but also provides concrete benefits for patients, in the form of shorter waiting times and routes on the way to diagnosis and improved treatment success.

“Using these new technologies from Collexis and Microsoft, Asklepios is breaking new ground with this innovative form of medical knowledge management, and we also aim to underline our market-leading role as Europe’s largest private clinic operator,” explains Dr. Tobias Kaltenbach, Chief Executive Officer of Asklepios Kliniken.

With more than 32,000 employees in more than 100 facilities in Europe and the United States, Asklepios needed a way to make professional information, past experience with patients, disease patterns and treatment methods quickly available to doctors across the organization. The project was undertaken within the framework of the Asklepios Future Hospital, a program which aims to set new standards of quality and efficiency in the Healthcare service and to implement consistency throughout all processes. Microsoft Corp. and SyynX

Solutions, a Collexis subsidiary, belong to the more than 20 companies that work with Asklepios in this program.

“We are pleased to see Asklepios, Collexis’ initial healthcare customer, expand its engagement with the addition of Microsoft Office Communications Server 2007. Together with the Collexis Expert Profiling system, internal knowledge that is invariably bound up with individuals will be made available to the entire community in the most advanced manner that will benefit the patients and the physicians,” explains Christian Herzog, General Manager of Life Sciences for Collexis Holdings, Inc.

The Asklepios Group of Hamburg, Germany — a Collexis HealthCare customer since 2005 — began its engagement with the implementation of the Expert Profiling system to develop and maintain a central knowledge and skills management system to enhance collaboration among its clinics and providers. The solution was implemented by Collexis’ German subsidiary SyynX Solutions.

In addition to Asklepios, Collexis is bringing its innovative technology to other healthcare providers, research organizations and universities world-wide, including the National Institutes of Health, Mayo Clinic Libraries; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Bristol-Myers Squibb, and the World Health Organization.

via: Collexis

Bookmark and Share